Ananda Pharma PLC 2025 Kick-Off Webinar

RNS Number : 1686U

Ananda Pharma PLC

22 January 2025

 

22 January 2025

 

ANANDA PHARMA PLC 

("Ananda" or the "Company") 

 

Webinar Presentation

 

Ananda Pharma plc (AQSE: ANA), a Company focused on the the development of cannabinoid based therapies for the treatment of a range of complex conditions, is pleased to announce that to kick off 2025, Melissa Sturgess, CEO, will provide a live update presentation and Q&A session via the Company's InvestorHub on Wednesday, 29 January 2025, at 12:30 GMT.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the webinar page up until 27 January 2025, 12:30 GMT, or at any time during the live presentation.

 

Investors can sign up to the webinar for free via: https://investors.anandapharma.co.uk/webinars/LeoVy6-2025-kick-off

 

To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:  

  

·              Investor Hub: https://investors.anandapharma.co.uk/s/ea8f93

·              Instagram: https://www.instagram.com/anandapharmaplc/

·              LinkedIn:  https://www.linkedin.com/company/anandapharma

·              X: https://twitter.com/AnandaPlc

·              Investor Meet Company: https://www.investormeetcompany.com/ananda-pharma-plc/register-investor

  

-Ends-  

  

The Directors of the Company accept responsibility for the contents of this announcement.  

  

ANANDA PHARMA PLC	[phone]
	[e-mail]
Chief Executive Officer
Melissa Sturgess
Finance Director
Jeremy Sturgess-Smith
SP ANGEL CORPORATE FINANCE LLP	[phone]
Corporate Finance
Richard Morrison
Corporate Broking
Abigail Wayne
Rob Rees
Yellow Jersey PR (media enquiries) Sarah MacLeod Charles Goodwin Zara McKinlay	[phone] [e-mail]

 

 

About Ananda Pharma  

  

Ananda is an AQSE-listed life sciences company focused on the research and clinical development of cannabinoid therapies for a range of complex conditions.

For more information, please visit: www.anandapharma.co.uk

   

https://investors.anandapharma.co.uk/link/DexQwr

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRAPPUBUGUPAGAG